CytomX Therapeutics CTMX
NASDAQ CTMX
$2.63 -0.09 (-3.31%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Non-Current Deffered Revenue (2014 - 2026)

Updated

CytomX Therapeutics (CTMX) posted Non-Current Deffered Revenue of $30.62 million for Q2 2026, up 199.0% from $10.24 million a year earlier.

Analysis

CytomX Therapeutics (CTMX) Non-Current Deffered Revenue (2014 - 2026) Analysis & Trends

At the end of FY2025, CytomX Therapeutics' Non-Current Deffered Revenue came in at $1.59 million, down 94.1% from FY2024.

  • Annual Non-Current Deffered Revenue has declined for five consecutive years, with a five-year compound annual growth rate of -64.4% (FY2020 to FY2025).
  • In prior years, CytomX Therapeutics' Non-Current Deffered Revenue was $26.86 million in FY2024 (-66.4%), $80.05 million in FY2023 (-55.5%), $180.06 million in FY2022 (-26.2%) and $243.94 million in FY2021 (-11.8%).
  • The Q2 2026 figure stands as the highest quarterly Non-Current Deffered Revenue since Q3 2024.
  • On a year-over-year basis, Non-Current Deffered Revenue increased in 1 of the last eight quarters, with an average decline of 44.3%.
  • The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q2 2026, with growth of 199.0%; the weakest was Q4 2025, with a decline of 94.1%.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $979,000 (Q1 2026), $1.59 million (Q4 2025) and $5.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 CytomX Therapeutics 592.69 Mn -364.98 Mn - 30.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.62 Mn
Mar 31, 2026 979,000.00
Dec 31, 2025 1.59 Mn
Sep 30, 2025 5.54 Mn
Jun 30, 2025 10.24 Mn
Mar 31, 2025 16.21 Mn
Dec 31, 2024 26.86 Mn
Sep 30, 2024 33.56 Mn
Jun 30, 2024 36.71 Mn
Mar 31, 2024 59.74 Mn
Dec 31, 2023 80.05 Mn
Sep 30, 2023 112.26 Mn
Jun 30, 2023 140.87 Mn
Mar 31, 2023 157.13 Mn
Dec 31, 2022 180.06 Mn
Sep 30, 2022 168.33 Mn
Jun 30, 2022 203.91 Mn
Mar 31, 2022 222.09 Mn
Dec 31, 2021 243.94 Mn
Sep 30, 2021 254.26 Mn
API Access

CytomX Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CTMX&period=max&api_key=YOUR_API_KEY